a 71623 has been researched along with azaserine in 2 studies
Studies (a 71623) | Trials (a 71623) | Recent Studies (post-2010) (a 71623) | Studies (azaserine) | Trials (azaserine) | Recent Studies (post-2010) (azaserine) |
---|---|---|---|---|---|
27 | 0 | 2 | 624 | 3 | 37 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, RH; Longnecker, DS; Povoski, SP; Roebuck, BD; Zhou, W | 2 |
2 other study(ies) available for a 71623 and azaserine
Article | Year |
---|---|
Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Topics: Animals; Azaserine; Carcinogens; Cell Division; Cholecystokinin; Male; Pancreas; Pancreatic Neoplasms; Peptide Fragments; Precancerous Conditions; Rats; Rats, Inbred Lew; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1994 |
Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Topics: Animals; Azaserine; Cholecystokinin; Chronic Disease; Male; Organ Size; Pancreas; Pancreatic Neoplasms; Pancreatitis; Peptide Fragments; Precancerous Conditions; Rats; Rats, Inbred Lew; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1993 |